FDA Approves New Drug For Treating Liver Cancer

The U.S. Food and Drug Administration approved the drug Stivarga as a second-line treatment for liver cancer. Stivarga is a drug from Bayer HealthCare Pharmaceuticals Inc., which is based in Germany.